4 completed, 2 unknown, 1 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Unknown 2, Withdrawn 1 |
Follow Stroke, Acute: new trials by email Literature Review of Stroke, Acute trials Research Report on Stroke, Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Insulin for Hyperglycemia in Stroke Trial Analog Insulin, Human insulin - Hyperglycemia, Stroke, Acute | Phase 4 | Completed | National Institute of Neurosciences and Hospital, Dhaka | 452 | 2021-04-05 | 2021-12-06 |
| Omega 3 and Ischemic Stroke; Fish Oil as an Option Omega-3 fish oil - Ischemic Stroke, Neurological Injury | Phase 4 | Unknown | King Fahad Medical City | 60 | 2020-09-01 | 2020-05-14 |
| Xingnaojing for Mild-to-severe Acute Ischemic Stroke Xingnaojing injection, Xingnaojing placebo injection, Standard care - Acute Ischemic Stroke, Stroke, Acute | Phase 4 | Unknown | Dongzhimen Hospital, Beijing | 1200 | 2020-03-19 | 2021-04-01 |
| A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke Naloxone hydrochloride 5.0mg/5ml, Sodium Chloride 45mg/5ml - Stroke, Acute | Phase 4 | Completed | Samjin Pharmaceutical Co., Ltd. | 446 | 2018-08-07 | 2023-08-14 |
| Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients Kallikrein - Stroke, Acute | Phase 4 | Completed | The Second Hospital of Hebei Medical University | 80 | 2017-07-01 | 2021-03-01 |
| Stroke Treatment With Acute Reperfusion and Simvastatin Simvastatin - Stroke, Acute | Phase 4 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 104 | 2009-04-01 | 2016-12-21 |
| Blood Pressure Lowering in Acute Stroke Trial Valsartan - Stroke, Acute | Phase 4 | Withdrawn | Stanford University | 2007-08-01 | 2016-05-09 |
Stroke (7) · Ischemic Stroke (2) · Brain Injuries (1) · Brain Ischemia (1) · Cerebral Infarction (1) · Disease (1) · Hyperglycemia (1) · Insulin Resistance (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Trauma, Nervous System (1)
Brain Diseases (7) · Cardiovascular Diseases (7) · Central Nervous System Diseases (7) · Cerebrovascular Disorders (7) · Vascular Diseases (7) · Nervous System Diseases (6) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2) · Brain Infarction (1) · Brain Ischemia (1) · Craniocerebral Trauma (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Infarction (1) · Ischemia (1)
Fish Oils (1) · Insulin (1) · Insulin Aspart (1) · Insulin Glargine (1) · Insulin, Isophane (1) · Kallikreins (1) · Naloxone (1) · Simvastatin (1) · Sodium Chloride (1) · Standard of Care (1) · Valsartan (1) · xingnaojing (1)
Dongzhimen Hospital, Beijing (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · King Fahad Medical City (1) · National Institute of Neurosciences and Hospital, Dhaka (1) · Samjin Pharmaceutical Co., Ltd. (1) · Stanford University (1) · The Second Hospital of Hebei Medical University (1)
China (2) · Bangladesh (1) · South Korea (1) · Spain (1) · United States (1)
Carmen Jimenez, MD (1) · David Canovas, MD (1) · Dong Keun Hyun, M.D.,Ph.D (1) · Francisco Alonso, MD, PhD (1) · Francisco Rubio Borrego, MD, PhD (1) · Gregory Albers, M.D (1) · Joan Montaner, MD, PhD (1) · Jose Manuel Flores, MD (1) · Juan Arenillas, MD, PhD (1)